Cargando…

BCG orchitis

Intravesical immunotherapy with Bacillus Calmette-Guerin has been shown to decrease tumor recurrence and progression in urothelial carcinoma of the bladder. Its ubiquitous use is further substantiated by its low rates of complications. Our patient is a 63 year old male with a circuitous medical cour...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutrone, Joseph, Siegert, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558253/
https://www.ncbi.nlm.nih.gov/pubmed/31198685
http://dx.doi.org/10.1016/j.eucr.2019.100925
_version_ 1783425591255498752
author Cutrone, Joseph
Siegert, James J.
author_facet Cutrone, Joseph
Siegert, James J.
author_sort Cutrone, Joseph
collection PubMed
description Intravesical immunotherapy with Bacillus Calmette-Guerin has been shown to decrease tumor recurrence and progression in urothelial carcinoma of the bladder. Its ubiquitous use is further substantiated by its low rates of complications. Our patient is a 63 year old male with a circuitous medical course who presents with epididymoorchitis and scrotal abscess after his second three week cycle of maintenance BCG prompting scrotal exploration which revealed a non-viable testicle and large scrotal induration with abscess. Pathological analysis and initial cultures were negative for mycobacterium but acid-fast cultures eventually demonstrated mycobacterium three months later.
format Online
Article
Text
id pubmed-6558253
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65582532019-06-13 BCG orchitis Cutrone, Joseph Siegert, James J. Urol Case Rep Oncology Intravesical immunotherapy with Bacillus Calmette-Guerin has been shown to decrease tumor recurrence and progression in urothelial carcinoma of the bladder. Its ubiquitous use is further substantiated by its low rates of complications. Our patient is a 63 year old male with a circuitous medical course who presents with epididymoorchitis and scrotal abscess after his second three week cycle of maintenance BCG prompting scrotal exploration which revealed a non-viable testicle and large scrotal induration with abscess. Pathological analysis and initial cultures were negative for mycobacterium but acid-fast cultures eventually demonstrated mycobacterium three months later. Elsevier 2019-05-29 /pmc/articles/PMC6558253/ /pubmed/31198685 http://dx.doi.org/10.1016/j.eucr.2019.100925 Text en © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Cutrone, Joseph
Siegert, James J.
BCG orchitis
title BCG orchitis
title_full BCG orchitis
title_fullStr BCG orchitis
title_full_unstemmed BCG orchitis
title_short BCG orchitis
title_sort bcg orchitis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558253/
https://www.ncbi.nlm.nih.gov/pubmed/31198685
http://dx.doi.org/10.1016/j.eucr.2019.100925
work_keys_str_mv AT cutronejoseph bcgorchitis
AT siegertjamesj bcgorchitis